Arterial disease in lupus and secondary antiphospholipid syndrome: association with anti-beta2-glycoprotein I antibodies but not with antibodies against oxidized low-density lipoprotein

British Journal of Rheumatology
F I RomeroG R Hughes

Abstract

The prevalence and clinical significance of antibodies against beta2-glycoprotein I (anti-beta2GPI) and antibodies against oxidized low-density lipoprotein (anti-ox-LDL) were evaluated as potential indicators of arterial disease in patients with systemic lupus erythematosus (SLE) and SLE with secondary antiphospholipid syndrome (APS). IgG anti-beta2GPI and IgG anti-ox-LDL were measured by enzyme-linked immunosorbent assay (ELISA) in serum samples from 118 patients with SLE, including 40 with secondary APS. IgG anti-beta2GPI were positive in 17% (20/118) of SLE patients. The presence and titres of IgG anti-beta2GPI were strongly associated with a history of arterial thrombosis. Haemolytic anaemia was also significantly associated with the presence of IgG anti-beta2GPI. The prevalence of IgG anti-ox-LDL was 53% (63/118), but there was no association with arterial thrombosis. No correlation between the values of anti-ox-LDL and those of anti-beta2GPI was found. These results suggest that IgG anti-beta2GPI could be a marker for arterial thrombosis in SLE patients, while IgG anti-ox-LDL were not associated with arterial disease in this group of lupus patients.

Citations

Jun 8, 2001·Current Atherosclerosis Reports·Y Sherer, Y Shoenfeld
Jan 26, 2002·Joint, Bone, Spine : Revue Du Rhumatisme·O Meyer
Jul 10, 2003·Autoimmunity Reviews·Eiji MatsuuraYehuda Shoenfeld
Apr 12, 2007·Clinical Reviews in Allergy & Immunology·Pier Luigi MeroniMaria Orietta Borghi
Sep 12, 2003·Current Rheumatology Reports·José Delgado Alves, Bruno Grima
Mar 24, 2011·Expert Review of Clinical Immunology·Maureen McMahonBrian J Skaggs
Jul 12, 2008·Expert Opinion on Investigational Drugs·Maureen McMahon, Ernest Brahn
Feb 2, 2015·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Mohammed M Al GadbanSamar M Hammad
Dec 18, 2007·Current Opinion in Immunology·Maureen McMahon, Bevra H Hahn
Oct 28, 2004·Thrombosis Research·Panayiotis G Vlachoyiannopoulos, Michael Samarkos
Nov 16, 2013·Autoimmunity·Johanna T Gustafsson, Elisabet Svenungsson
Jul 19, 2014·Rheumatic Diseases Clinics of North America·Maureen McMahon, Brian Skaggs
Jul 6, 2000·Baillière's Best Practice & Research. Clinical Rheumatology·D Alarcón-Segovia, A R Cabral
Jan 25, 2002·Current Controlled Trials in Cardiovascular Medicine·Joel G Ray, Frits R Rosendaal
Jul 20, 2010·Journal of Autoimmunity·Panayiotis G Vlachoyiannopoulos, John G Routsias
Aug 9, 2005·Rheumatic Diseases Clinics of North America·Janet E Pope
May 11, 2000·Lupus·G R Hughes
Apr 20, 2004·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·M Akif OztürkHakan Göker
Oct 8, 1999·Arthritis Care and Research : the Official Journal of the Arthritis Health Professions Association·K QushmaqD V Devine
Oct 17, 2001·Circulation·E SvenungssonJ Frostegård
Sep 9, 2005·Current Opinion in Lipidology·Sander I van LeuvenErik S Stroes
Aug 30, 2005·Annals of the New York Academy of Sciences·Kazuko KobayashiEiji Matsuura
Aug 22, 2002·International Reviews of Immunology·Eiji MatsuuraYehuda Shoenfeld
Jun 13, 2020·International Journal of Molecular Sciences·Paul R J AmesFabrizio Gentile
Oct 25, 2003·Renal Failure·Lenka FialováVĕra Certíková
Jul 9, 2004·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Danielle Nicolo, Marc Monestier
Oct 27, 2004·Seminars in Arthritis and Rheumatism·Yaniv ShererYehuda Shoenfeld

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antiphospholipid Syndrome

Antiphospholipid syndrome or antiphospholipid antibody syndrome (APS or APLS), is an autoimmune, hypercoagulable state caused by the presence of antibodies directed against phospholipids.